Mira Pharmaceuticals Highlights Preclinical Ketamir-2 Updates; Says Is Hopeful Results Will Enable Co. To File An NDA With FDA By End Of This Year
Mira Pharmaceuticals Highlights Preclinical Ketamir-2 Updates; Says Is Hopeful Results Will Enable Co. To File An NDA With FDA By End Of This Year
Mira Pharmicals重點介紹臨床前Ketamir-2的最新動態；表示希望結果將使Co.在今年年底之前向美國食品藥品管理局提交保密協議
Mira Pharmaceuticals Highlights Preclinical Ketamir-2 Updates; Says Is Hopeful Results Will Enable Co. To File An NDA With FDA By End Of This Year
Mira Pharmicals重點介紹臨床前Ketamir-2的最新動態；表示希望結果將使Co.在今年年底之前向美國食品藥品管理局提交保密協議
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。